A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes
- PMID: 33977164
- PMCID: PMC8103082
- DOI: 10.1002/hsr2.282
A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes
Abstract
Background and aims: As a curative procedure, hematopoietic stemcell transplantation (HSCT) is an approved treatment for many malignant orbenign hematologic and non-hematologic diseases. There are different outcomes of HSCT, as well as several parameters influencing these outcomes.
Methods: We had searched scientific sources like Web ofScience and PubMed with a combination of keywords such as HSCT, engraftment,survival, outcomes, etc. Totally, 80 articles were included.
Results: Here we have reviewed the effective factors onmain outcomes of HSCT including engraftment, survival, graft versus hostdisease, and Mobilization. Also, the prediction of hematological reconstitutionand some novel suggestions leading to better outcomes are reviewed.
Conclusion: The study will be applicable for improvedmanagement of autologous and allogeneic HSCT process to increase the procedureefficiency.
Keywords: engraftment; graft vs host disease; hematopoietic stem cell transplantation; outcomes; relapse; survival.
© 2021 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.Stem Cell Res Ther. 2021 Apr 20;12(1):246. doi: 10.1186/s13287-021-02304-x. Stem Cell Res Ther. 2021. PMID: 33879242 Free PMC article.
-
[Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):465-471. doi: 10.3760/cma.j.issn.0253-2727.2023.06.004. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 37550201 Free PMC article. Chinese.
-
Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.Transplant Cell Ther. 2021 Oct;27(10):877.e1-877.e8. doi: 10.1016/j.jtct.2021.07.012. Epub 2021 Jul 18. Transplant Cell Ther. 2021. PMID: 34284148
-
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy.Transplant Cell Ther. 2023 Jan;29(1):41.e1-41.e9. doi: 10.1016/j.jtct.2022.10.029. Epub 2022 Nov 4. Transplant Cell Ther. 2023. PMID: 36343893 Clinical Trial.
-
Oncolytic virotherapy in hematopoietic stem cell transplantation.Hum Immunol. 2021 Sep;82(9):640-648. doi: 10.1016/j.humimm.2021.05.007. Epub 2021 Jun 9. Hum Immunol. 2021. PMID: 34119352 Review.
Cited by
-
Distributions of the HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 alleles and haplotype frequencies of 1763 stem cell donors in the Colombian Bone Marrow Registry typed by next-generation sequencing.Front Immunol. 2023 Jan 9;13:1057657. doi: 10.3389/fimmu.2022.1057657. eCollection 2022. Front Immunol. 2023. PMID: 36700199 Free PMC article.
-
Insights into gut microbiomes in stem cell transplantation by comprehensive shotgun long-read sequencing.Sci Rep. 2024 Feb 19;14(1):4068. doi: 10.1038/s41598-024-53506-1. Sci Rep. 2024. PMID: 38374282 Free PMC article.
-
Predictive factors for engraftment kinetics of autologous hematopoietic stem cells in children.Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S291-S298. doi: 10.1016/j.htct.2024.09.2481. Epub 2024 Nov 7. Hematol Transfus Cell Ther. 2024. PMID: 39616107 Free PMC article.
-
Worked to the bone: antibody-based conditioning as the future of transplant biology.J Hematol Oncol. 2022 May 19;15(1):65. doi: 10.1186/s13045-022-01284-6. J Hematol Oncol. 2022. PMID: 35590415 Free PMC article. Review.
-
Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies.Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S59-S70. doi: 10.1016/j.htct.2023.10.008. Epub 2023 Dec 29. Hematol Transfus Cell Ther. 2024. PMID: 38177056 Free PMC article.
References
-
- Fürst D, Müller C, Vucinic V, et al. High‐resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220‐3229. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials